New tentative approval for Sandoz Inc drug rifaximin

Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There are twenty-nine patents protecting this compound. Drug patent litigation for…

Source


Comments are closed.

Biotechblog